AU2034601A - Crystalline form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic acid - Google Patents

Crystalline form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic acid

Info

Publication number
AU2034601A
AU2034601A AU20346/01A AU2034601A AU2034601A AU 2034601 A AU2034601 A AU 2034601A AU 20346/01 A AU20346/01 A AU 20346/01A AU 2034601 A AU2034601 A AU 2034601A AU 2034601 A AU2034601 A AU 2034601A
Authority
AU
Australia
Prior art keywords
ethoxy
butoxycarbonylaminophenyl
tert
phenyl
crystalline form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20346/01A
Inventor
Martin Bohlin
Maria Boije
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9904417A external-priority patent/SE9904417D0/en
Priority claimed from SE0001422A external-priority patent/SE0001422D0/en
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2034601A publication Critical patent/AU2034601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
AU20346/01A 1999-12-03 2000-11-29 Crystalline form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic acid Abandoned AU2034601A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9904417A SE9904417D0 (en) 1999-12-03 1999-12-03 Crystalline form
SE9904417 1999-12-03
SE0001422 2000-04-17
SE0001422A SE0001422D0 (en) 2000-04-17 2000-04-17 Crystalline form
PCT/SE2000/002379 WO2001040165A1 (en) 1999-12-03 2000-11-29 Crystalline form of 3-{4-[2-(4-tert-butoxycarbonylaminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid

Publications (1)

Publication Number Publication Date
AU2034601A true AU2034601A (en) 2001-06-12

Family

ID=26655079

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20346/01A Abandoned AU2034601A (en) 1999-12-03 2000-11-29 Crystalline form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic acid

Country Status (3)

Country Link
AR (1) AR026704A1 (en)
AU (1) AU2034601A (en)
WO (1) WO2001040165A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1198699A (en) 1997-10-27 1999-04-23 Dr. Reddy's Research Foundation Novel heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
RU2235094C2 (en) 1997-10-27 2004-08-27 Др. Редди`З Лабораториз Лимитед Beta-aryl-alpha-hydroxy-substituted alkylcarboxylic acids, methods for their preparing, intermediate compounds, methods for their preparing, pharmaceutical composition, methods for treatment or prophylaxis of diseases based on new compounds
HUP0101110A3 (en) 1997-10-27 2002-06-28 Reddys Lab Ltd Dr Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
JP2002528535A (en) 1998-10-29 2002-09-03 ドクター・レディーズ・リサーチ・ファウンデーション An improved method for producing new antidiabetic agents
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26634A1 (en) * 1998-06-04 2004-12-20 Astra Ab NOVEL 3-ARYL PROPIONIC ACID DERIVATIVES AND THE LIKE
SE9801990D0 (en) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs

Also Published As

Publication number Publication date
AR026704A1 (en) 2003-02-26
WO2001040165A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
AU3957800A (en) Crystalline r- guanidines, arginine or (l) -arginine (2(s)) -2- ethoxy -3-(4- (2-(10(h) -phenoxazin -10-yl)ethoxy}phenyl)propanoate
IL149577A0 (en) Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid
IL149516A0 (en) Comminuted form of (s)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
IL145958A0 (en) Polymorphic form of arginine salt of (2s)-3-[4-[2-phenoxazin-10-yl)ethoxy] phenyl]2-ethoxypropanoic acid, processes for the preparation thereof and pharmaceutical compositions containing the same
EE200000659A (en) Ethyl esters of 4- (3,5-bis-trifluoromethyl-benzylamino) -2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid or their salts and methods for their preparation
AU2003278406A1 (en) Amorphous form of esomeprazole salts
AU2034601A (en) Crystalline form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic acid
PT1599455E (en) 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis
AU2034701A (en) Comminuted form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic
AU5248601A (en) Novel amorphous form of omeprazole salts
AU2001267416A1 (en) N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23
AU2001286163A1 (en) An improved process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives
WO2005073194A3 (en) Solid forms of montelukast acid
AU2001244098A1 (en) Pharmaceutical composition containing 3-(4(2-phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxy propanoicacid
AU2001240702A1 (en) Derivatives of p- hydroxy phenyl propionic acid as antiproliferative agents
SI1237855T1 (en) Crystalline form of (s)-2 ethoxy-3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl) propanoic acid
AU2001290743A1 (en) Solid salt forms of n-(2-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)ethyl)-2-oxo-1-piperidineacetamide
NO20035236D0 (en) pharmaceutical   combination   comprehensive   either   (S)   -2-ethoxy-3   (4-   (2-   (4-methanesulfonyloxyphenyl)   ethoxy)   phenyl)   acid   or   3-   (4-   (2-   (4-tert-butoxycarbonylaminophenyl)   ethoxy)   phenyl)   -   (S)   -2-
AU2003277855A1 (en) Amorphous form of(-)-}2-}4-}(4-chlorophenyl)-phenyl methyl}-1-piperazinyl) ethoxy) acetic acid dihydrochloride (levocetririzine dihydrochloride)
NO20035235D0 (en) A pharmaceutical combination comprising either (S) -2-ethoxy-3- (4- (2- (4-methanesulfonyloxyphenyl) ethoxy) phenyl) propanoic acid or 3- (4- (2- (4-tert-butoxycarbonylaminophenyl) ethoxy) phenyl)
ATE348807T1 (en) SULFURIC ACID MONO-(3-(Ä1-(2-(4-FLUORO-PHENYL)-ETHYL)-PIPERIDINE-4-YLÜ-HYDROXY-METHYL)-2-METHOXY-PHENYL)ESTER
AU2002214422A1 (en) New use of 2-(4-isobutylphenyl)propionic acid
AU2001289723A1 (en) Novel use of difluoromalonic acid esters
AU2002220571A1 (en) (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6 -tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propio nic acid isopropyl ester, its preparation and its use
AU1572201A (en) Crystalline salts of (S)-4-(3-(N-(2-(4-(5-carbamoyl-2-pyridyloxy)phenyl)-1,1- dimethylethyl)amino)-2-hydroxypropoxy)indole

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase